SC inmate will be executed by lethal injection. Here’s how the method will work
It will be the first time South Carolina has executed a prisoner in more than a decade, and a new procedure will be used on ...
STAT1d
Medicaid must prepare to cover twice-yearly HIV prevention injection
Twice-a-year-PReP will only fulfill its potential if Medicaid takes decisive action to ensure it is accessible to the ...
Iron given through the vein found to correct anemia in pregnant women faster than iron taken orally
Researchers found that a medicine called ferric carboxymaltose given in drip through the vein works faster and better than an ...
Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
The FDA has approved Roche's Ocrevus Zunovo for relapsing and primary progressive multiple sclerosis, offering the first ...
Multiple Sclerosis News Today4d
Ocrevus Zunovo now approved in US to treat relapsing MS, PPMS
The FDA approved Ocrevus Zunovo, a subcutaneous formulation of Ocrevus, for adults with relapsing forms of MS and PPMS ...
US FDA approves injectable version of Roche's multiple sclerosis therapy
The subcutaneous or under-the-skin therapy called Ocrevus Zunovo has the potential to expand treatment options to centers ...
Medscape6d
FDA Okays Subcutaneous Ocrelizumab for MS
Subcutaneous administration of ocrelizumab was noninferior to intravenous infusion in the phase 3 OCARINA II trial.
Business Wire6d
Rising Pharmaceuticals announces commercial availability of Edetate calcium disodium injection in the United States
Rising Pharmaceuticals, Inc. announces commercial availability of Edetate calcium disodium injection in the United States ...
STAT6d
FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug
Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...
Business Wire7d
FDA Approves Genentech’s Tecentriq Hybreza, the First and Only Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
Cure Today7d
FDA Approves Subcutaneous Tecentriq Formulation
Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin ...
Targeted Oncology8d
Dexamethasone Prophylaxis Reduces IRRs in Amivantamab Treatment
Pretreatment with dexamethasone significantly reduced infusion-related reactions in patients receiving amivantamab for advanced lung cancer, according to findings from the SKIPPirr study.